|
⚲
|
| Keyboard |
| Curaxis Pharmaceutical Corp
✚
|
|
|---|---|
| CIK # | 0001434893 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001434893] | |
| 10-Q | [0001434893] | |
| 4 | [0001434893] | |
| 8-K | [0001434893] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Curaxis Pharmaceutical Corp | |
| Geaslen Judith ST | |
| Wright Timothy R | |
| Gothner K Ivan F | |
| Novak Terence | |
| George Michael W | |
| Leary Stephen J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Curaxis Pharmaceutical Corp CURX.PK
Emplyee Stock Option · derivative
|
2012-05-07 | Grant | 300,000 | $0.00 | |
|
Curaxis Pharmaceutical Corp CURX.PK
Employee Stock Option · derivative
|
2012-05-07 | Grant | 500,000 | $0.00 | |
|
Curaxis Pharmaceutical Corp CURX.PK
Common Stock
|
2012-01-19 | Grant | 150,000 | $0.04 | 6,000 |
|
Curaxis Pharmaceutical Corp CURX.PK
Common Stock
|
2012-01-19 | Grant | 150,000 | $0.04 | 6,000 |
|
Curaxis Pharmaceutical Corp CURX.PK
Common Stock
|
2012-01-19 | Grant | 200,000 | $0.04 | 8,000 |
|
Curaxis Pharmaceutical Corp CURX.PK
Common Stock
|
2012-01-19 | Grant | 200,000 | $0.04 | 8,000 |